Here are three biotech layoffs Becker’s has reported on since Sept. 12:
- In September, 2seventybio, which makes T-cell drugs for cancer treatment, laid off 176 employees, or 40% of its workforce.
- In October, Sana Biotechnology, a cell and gene therapy company, laid off 29% of its workforce as it looks to focus on its ex vivo cell therapy line.
- In November, Sangamo Therapeutics, a company focusing on the treatment of genetic conditions, laid off 40% of its workforce and closed down its headquarters.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
